Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohorts

F.H. Duits, K.E.J. Wesenhagen, L. Ekblad, E. Wolters, E.A.J. Willemse, P. Scheltens, W.M. van der Flier, C.E. Teunissen, P.J. Visser, B.M. Tijms, Alzheimer's Disease Neuroimaging Initiative

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Article number2
Number of pages25
JournalAlzheimer's Research & Therapy
Volume13
Issue number1
DOIs
Publication statusPublished - 4 Jan 2021

Keywords

  • accuracy
  • alzheimer's disease
  • cerebrospinal-fluid biomarker
  • csf biomarkers
  • csf tau
  • decline
  • dementia
  • diagnosis
  • gaussian mixture modelling
  • markers
  • national institute
  • pathology
  • prognosis
  • signature
  • Prognosis
  • CEREBROSPINAL-FLUID BIOMARKER
  • DEMENTIA
  • MARKERS
  • CSF BIOMARKERS
  • PATHOLOGY
  • SIGNATURE
  • CSF tau
  • NATIONAL INSTITUTE
  • Alzheimer's disease
  • DIAGNOSIS
  • ACCURACY
  • DECLINE
  • Gaussian mixture modelling

Cite this